We’ve updated our antenatal and newborn screening information for public and professionals following a change to the vaccination schedule for babies.
Back in November 2016 and March 2017 we published blog articles about the additional option of non-invasive prenatal testing (NIPT) to the fetal anomaly screening pathway.
We have published new information that describes the checks and audits that are needed for the sickle cell and thalassaemia (SCT) screening pathway.
If you work in ultrasound or radiology you will be well aware there’s a national shortage of trained staff. Many ultrasound departments rely on agency sonographers.
We use key performance indicator (KPI) data to measure how the NHS screening programmes are performing.
We offer screening for sickle cell and thalassaemia (SCT) to all pregnant women. We also offer to screen the baby’s biological father if the mother is found to be a carrier of or have a sickle cell or thalassaemia condition.
The NHS Fetal Anomaly Screening Programme (FASP) offers screening to pregnant women so they can find out how likely it is that their baby has Down’s (Trisomy 21 or T21), Edwards’ (T18) or Patau’s (T13) syndromes or one of a …
We published a blog in November about non-invasive prenatal testing (NIPT).
Our 3 antenatal screening programmes have joined forces with the national Screening Quality Assurance Service (SQAS) team to hold 8 regional workshops during 2017.
The National Antenatal Infection Screening Monitoring (NAISM) team in Public Health England’s National Infection Service (NIS) has published the 2015 annual summary report on antenatal screening for infectious diseases.